ABSTRACT
Random sequential adsorption of linear and square particles with excluded volume interaction is studied numerically on planar lattices considering Gaussian distributions of lateral sizes of the incident particles, with several values of the average µ and of the width-to-average ratio w. When the coverage θ is plotted as function of the logarithm of time t, the maximum slope is attained at a time t_{M} of the same order of the time τ of incidence of one monolayer, which is related to the molecular flux and/or sticking coefficients. For various µ and w, we obtain 1.5τ
ABSTRACT
OBJECTIVE: To evaluate effects of intra-articular and extracapsular reconstruction of the cranial cruciate ligament (CCL) on metabolism of articular cartilage as reflected by concentrations of chondroitin sulfate epitopes 3B3 and 7D4 in synovial fluid. ANIMALS: 13 adult dogs. PROCEDURE: Each dog underwent unilateral CCL transection (CCLT). One month after CCLT, sham CCL reconstruction (3 dogs), intra-articular CCL reconstruction (5), or extracapsular CCL reconstruction (5) was performed. Synovial fluid was collected by direct arthrocentesis from CCLT and contralateral stifle joints immediately before (time 0) and 1, 3, and 5 months after CCLT. Fluid was examined for concentrations of 3B3 and 7D4 epitopes and total sulfated glycosaminoglycan (GAG) content. RESULTS: Concentrations of 3B3, 7D4, and GAG, 3B3:GAG, or 7D4:GAG in CCLT joints did not differ significantly among treatment groups nor in the ratios of these variables in CCLT joints to contralateral joints at 3 months. In a longitudinal analysis, concentrations of 3B3 and 7D4, 3B3:GAG, and 7D4:GAG in CCLT joints in all groups changed significantly with time, but we did not detect time X group interactions. CONCLUSIONS AND CLINICAL RELEVANCE: Transection of CCL resulted in significant perturbation in articular cartilage metabolism as reflected by alterations in concentrations of 3B3 and 7D4 in synovial fluid. These changes over time were not significantly influenced by method of CCL reconstruction. We did not find evidence that surgical stabilization of CCL-deficient joints by intra-articular or extracapsular techniques had any effect on preventing alterations in composition of synovial fluid that have been associated with secondary osteoarthritis.
Subject(s)
Anterior Cruciate Ligament/surgery , Cartilage, Articular/metabolism , Chondroitin Sulfates/immunology , Dogs/surgery , Epitopes/biosynthesis , Synovial Fluid/metabolism , Animals , Anterior Cruciate Ligament/metabolism , Antigens/analysis , Antigens/biosynthesis , Chondroitin Sulfates/biosynthesis , Cross-Sectional Studies , Enzyme-Linked Immunosorbent Assay , Female , Longitudinal Studies , Male , Stifle/surgeryABSTRACT
OBJECTIVE: To evaluate effects of an orally administered mixture of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate (CS-G-M) on articular cartilage metabolism in dogs with cranial cruciate ligament (CCL) deficient and reconstructed knees, as reflected by concentrations of synovial fluid 3B3, 7D4 and total sulfated glycosaminoglycan (GAG). METHODS: Sixteen adult dogs that underwent unilateral CCL transection were randomized into four groups. Thereafter, group I (N=3) had a sham CCL reconstruction, group II (N=3) had CS-G-M and sham CCL reconstruction, group III (N=5) had CCL reconstruction, and group IV (N=5) had CS-G-M and CCL reconstruction. Synovial fluid collected at 0, 1, 3 and 5 months was examined by ELISA for 3B3 and 7D4 epitope, and by DMMB assay for total GAG. RESULTS: Synovial fluid from CCL transected knees of CS-G-M treated dogs contained significantly elevated concentrations of 3B3 (P=0.029), 7D4 (P=0.036) and 7D4/GAG (P=0.007) in comparison to controls, in a cross-sectional analysis at 3 months. Furthermore, 7D4 and 7D4/GAG concentrations remained significantly elevated (P=0.012) in CCL transected knees of CS-G-M treated dogs over the 5 month period. However, when epitope concentrations were expressed as a ratio of CCL-transected to contralateral non-operated knee, treatment effect of CS-G-M was no longer significant. Reconstruction of the CCL had no significant effect on synovial fluid epitope. CONCLUSIONS: Administration of CS-G-M was associated with altered concentrations of 3B3 and 7D4 epitope in synovial fluid, suggesting that these compounds may act to modulate articular cartilage matrix metabolism in vivo.
Subject(s)
Cartilage, Articular/drug effects , Chondroitin Sulfates/pharmacology , Glucosamine/pharmacology , Glycosaminoglycans/metabolism , Manganese Compounds/pharmacology , Synovial Fluid/chemistry , Administration, Oral , Animals , Chondroitin Sulfates/administration & dosage , Cross-Sectional Studies , Dogs , Female , Glucosamine/administration & dosage , Knee Joint/physiopathology , Ligaments, Articular/physiopathology , Longitudinal Studies , Male , Manganese Compounds/administration & dosageABSTRACT
Nonresonant laser-induced thermal acoustics is used with heterodyne detection to measure temperature (285-295 K) and a single component of velocity (20-150 m/s) in an atmospheric pressure, subsonic, unseeded air jet. Good agreement is found with Pitot-tube measurements of velocity (0.2% at 150 m/s and 2% at 20 m/s) and the isentropic expansion model for temperature (0.3%).
ABSTRACT
Using laser-induced thermal acoustics (LITA), the speed of sound in room air (1 atm) is measured over the temperature range 300-650 K. Since the LITA apparatus maintains a fixed sound wavelength as temperature is varied, this temperature range simultaneously corresponds to a sound frequency range of 10-15 MHz. The data are compared to a published model and typically agree within 0.1%-0.4% at each of 21 temperatures.
Subject(s)
Acoustics , Sound , Humans , TemperatureABSTRACT
We report a detailed investigation of nonresonant laser-induced thermal acoustics (LITA) for the single-shot measurement of the speed of sound (v(S)) in an oven containing room air. A model for the speed of sound that includes important acoustic relaxation effects is used to convert the speed of sound into temperature. A reference LITA channel is used to reduce uncertainties in v(S). Comparing thermocouple temperatures with temperatures deduced from our v(S) measurements and model, we find the mean temperature difference from 300 to 650 K to be 1% (+/-2sigma). The advantages of using a reference LITA channel are discussed.
Subject(s)
Dog Diseases/diagnostic imaging , Intervertebral Disc Displacement/veterinary , Lameness, Animal/diagnostic imaging , Lumbar Vertebrae , Animals , Dog Diseases/etiology , Dogs , Intervertebral Disc Displacement/complications , Intervertebral Disc Displacement/diagnostic imaging , Lameness, Animal/etiology , Male , Nerve Compression Syndromes/complications , Nerve Compression Syndromes/etiology , Nerve Compression Syndromes/veterinary , Radiography , Spinal NervesABSTRACT
In developing an avian model for 13-cis-retinoic acid (13cisRA) embryopathy, we found 13cisRA induced cardiovascular defects, especially Type I ventricular septal defects (VSDs) (Hart et al.: Teratology 41:463-472, '90). As the first step of investigating possible mechanisms, we have examined the light microscopic morphology of RA-induced cardiovascular defects in chick embryos. Fertilized eggs were injected via yolk sac with 150 micrograms 13cisRA in dimethylsulfoxide (DMSO), DMSO or mock injection on embryonic day 5 (E5). On E6, E7, or E8, surviving embryos were sacrificed and fixed in 10% formalin. Thoracic blocks were exised, embedded in paraffin and serially sectioned through the heart, base to apex. Slides were stained, screened for tissue orientation, then coded and evaluated without knowledge of treatment group. Examination of serial sections permitted qualitative evaluation of conotruncal ridge volume, mesenchymal organization, necrosis and extent of fusion. Extent of fusion was the only parameter influenced by 13cisRA treatment. On E6, ridge fusion was incomplete in all groups at comparable levels. On E7, ridge fusion in 13cisRA-treated embryos had not progressed as far proximally as in controls. By E8, there was a significant difference in the extent of fusion between 13cisRA-treated and non-RA-treated groups. We conclude 13cisRA-induced VSDs resulted from defective conotruncal ridge fusion and that the fusion defects did not result from decreased tissue volume, altered mesenchymal organization or increased necrosis.
Subject(s)
Heart Septal Defects/embryology , Isotretinoin/toxicity , Animals , Chick Embryo , Disease Models, Animal , Gestational Age , Heart Septal Defects/chemically inducedABSTRACT
The effects of 13-cis-retinoic acid on the developing chick embryo were investigated. Fertilized eggs were injected via the yolk sac with single 50 microliters doses of either 1.5 micrograms, 15 micrograms, or 150 micrograms of 13-cis-retinoic acid in dimethyl sulfoxide on varying days of incubation (embryonic days 2, 3, 4, 5, or 6). Control embryos were given solvent alone or a mock injection. The embryos were examined on day 14 of incubation. The effects of retinoic acid on mortality and total malformations were both dose and developmental-stage responsive. The defects caused by 13-cis-retinoic acid occurred in mesenchymal tissues derived in part from the cranial neural crest ectomesenchyme. The craniofacial and cardiovascular malformations produced in the chick are analogous to those seen in animal models of retinoid teratogenesis and in human fetuses exposed to 13-cis-retinoic acid during maternal therapy for cystic acne. Following 13-cis-retinoic acid treatment, craniofacial and specific cardiovascular malformations were increased significantly compared to those in matched solvent and mock treated controls. The greatest number of malformations occurred when 13-cis-retinoic acid was given after cranial neural crest cell migration was complete. We propose that the primary effect of 13-cis-retinoic acid is on region-specific localization and differentiation of the mesenchymal subpopulation of cranial neural crest cells.
Subject(s)
Abnormalities, Drug-Induced , Chick Embryo/drug effects , Neural Crest/drug effects , Tretinoin/toxicity , Animals , Dose-Response Relationship, Drug , Face/abnormalities , Female , Heart Defects, Congenital/chemically induced , Neural Crest/abnormalities , Pregnancy , Pregnancy OutcomeABSTRACT
We describe here the preparation of acridinium ester-labelled streptavidin, as a universal reagent for immunoassay detection. Streptavidin was labelled using an acridinium ester substituted with a N-hydroxysuccinimidyl group which at a pH of 7.4 reacts to form covalent bonds with the streptavidin amino groups. 63% of the added ester is covalently bound, and the chemiluminescence of the acridinium salt is unaffected by this labelling procedure. Labelled streptavidin can be detected down to less than 3 X 10(-19) mol in a detection reaction that takes 10 s. The labelled protein was used in a sandwich assay for mouse IgG using commercially available reagents, including biotin-labelled goat antibody to mouse IgG. In this assay the detection limit with 200 amol of the antigen (mouse IgG) using a 3 h coated tube procedure. The stability of labelled protein was examined under different buffer and temperature conditions. The labelled conjugates lost less than 20% of their original chemiluminescence activity when stored at 4 degrees C in the presence of sheep IgG and human serum albumin. In the absence of these proteins the labelled conjugates will adhere to the walls of the storage container and over 80% of the soluble activity is lost in 40 days. At 37 degrees C the chemiluminescence activity is lost rapidly and this loss is independent of buffer composition.
Subject(s)
Acridines , Bacterial Proteins/pharmacology , Immunoassay/methods , Succinimides , Animals , Esterification , Immunoglobulin G/analysis , Luminescent Measurements , Mice , StreptavidinABSTRACT
Calmodulin from both animal and plant sources is known to bind a number of hydrophobic compounds with resultant inhibition of calmodulin function. Some of these compounds, including certain phenothiazine and naphthalene sulfonamide derivatives, have been previously shown to be useful in the chromatographic isolation of calmodulin, when covalently linked to a solid support. With the exception of fluphenazine linked to epoxide-activated Sepharose, these resins have the undesirable characteristics of requiring high salt concentrations in the elution buffer for efficient elution of calmodulin, thus decreasing the selectivity for this protein. The synthesis of nine Sepharose-ligand affinity resins is reported. Some of the ligands are newly synthesized naphthalene sulfonamide and phenothiazine derivatives. The synthetic ligands have been coupled to three types of Sepharose: epoxide-activated, CNBr-activated, and carbodiimide-activated. The properties of these resins are reported and their relative abilities to act selectively in the isolation of calmodulin are compared. 2-Trifluoromethyl-10-aminopropyl phenothiazine (TAPP), when linked to epoxide-activated Sepharose, was found to be the most useful for calmodulin isolation in terms of its combined stability, capacity, and ability to select for calmodulin. This resin was found to behave as a true affinity resin. A quantitative evaluation of its affinity behavior was consistent with the presence of two high-affinity Ca2+-dependent phenothiazine binding sites on calmodulin, in apparent agreement with previous reports which involved the use of different methods.
Subject(s)
Calcium , Calmodulin/isolation & purification , Resins, Synthetic/chemical synthesis , Animals , Brain Chemistry , Cattle , Chromatography, Affinity , Ligands , Solubility , Structure-Activity Relationship , SwineSubject(s)
Cnidaria/enzymology , Firefly Luciferin , Luciferases/metabolism , Animals , Kinetics , Luminescent Measurements , Oxygen IsotopesABSTRACT
The structure of native luciferin from the bioluminescent coelenterate Renilla reniformis is shown to be 3,7-dihydro-2-(p-hydroxybenzyl)-6-(p-hydroxyphenyl)-8-benzylimidazo[1,2-a]pyrazin-3-one by mass spectral analysis of synthetic luciferin and the luciferin derived from a protein directly involved in the bioluminescent system. A previous report of the molecular weight of luciferin is shown to be incorrect by reexamination of the spectral data and by synthesis of two derivatives. Detailed analysis of kinetic, emission, and quantum yield data for the isolated and synthetic luciferins confirms this structure. Confirmation of this structure in a number of species from different phyla suggests a common substrate for a variety of bioluminescent marine organisms.